So you can take most of the cancer of the uterus and say that didn't need to happen
doi: 10.1016/j.neurobiolaging.2012.04.009 53 KellyPMcCleanPLAckermannMKonerdingMAHlscherCMitchellCA
KEY TAKEAWAYS BY PRODUCT Ozempic dominated the GLP-1 agonists market owing to its high adoption for the management of type 2 diabetes, wide geographic availability, and a strong brand recognition
Although it is challenging to develop individualized therapeutic regimens, personalized medicine, such as genetics and biomarker testing, can be used to tailor therapies to patients specific conditions, thereby improving the safety and efficacy of treatments (Sugandh et al., 2023)
Both treatments have risks and benefits
A rare and severe side effect of liraglutide is the development of thyroid cancer